Literature DB >> 24002713

Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease.

Bronwyn A Kingwell1, M John Chapman.   

Abstract

Entities:  

Keywords:  acute coronary syndrome; apolipoproteins; atherosclerosis; cerebrovascular disorders; lipoproteins, HDL; peripheral arterial disease; therapy

Mesh：

Substances：

Year:  2013        PMID： 24002713     DOI： 10.1161/CIRCULATIONAHA.113.002683

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

1.  Solution structure of discoidal high-density lipoprotein particles with a shortened apolipoprotein A-I.

Authors:  Stefan Bibow; Yevhen Polyhach; Cédric Eichmann; Celestine N Chi; Julia Kowal; Stefan Albiez; Robert A McLeod; Henning Stahlberg; Gunnar Jeschke; Peter Güntert; Roland Riek
Journal:  Nat Struct Mol Biol       Date:  2016-12-26       Impact factor: 15.369

Review 2.  HDL-targeted therapies: progress, failures and future.

Authors:  Bronwyn A Kingwell; M John Chapman; Anatol Kontush; Norman E Miller
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

3.  Maternal lipids, BMI and IL-17/IL-35 imbalance in concurrent gestational diabetes mellitus and preeclampsia.

Authors:  Weiping Cao; Xinzhi Wang; Tingmei Chen; Wenlin Xu; Fan Feng; Songlan Zhao; Zuxian Wang; Yu Hu; Bing Xie
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

4.  Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden.

Authors:  Yu Kataoka; Jordan Andrews; MyNgan Duong; Tracy Nguyen; Nisha Schwarz; Jessica Fendler; Rishi Puri; Julie Butters; Constance Keyserling; John F Paolini; Jean-Louis Dasseux; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

Review 5.  Lipoprotein-based drug delivery.

Authors:  Sara Busatto; Sierra A Walker; Whisper Grayson; Anthony Pham; Ming Tian; Nicole Nesto; Jacqueline Barklund; Joy Wolfram
Journal:  Adv Drug Deliv Rev       Date:  2020-08-11       Impact factor: 15.470

6.  Apolipoprotein Mimetic Peptide Inhibits Neutrophil-Driven Inflammatory Damage via Membrane Remodeling and Suppression of Cell Lysis.

Authors:  Michelle W Lee; Elizabeth Wei-Chia Luo; Carlos Silvestre-Roig; Yashes Srinivasan; Kiyotaka Akabori; Patricia Lemnitzer; Nathan W Schmidt; Ghee Hwee Lai; Christian D Santangelo; Oliver Soehnlein; Gerard C L Wong
Journal:  ACS Nano       Date:  2021-09-29       Impact factor: 15.881

7.  Extracellular vesicle therapeutics from plasma and adipose tissue.

Authors:  Dalila Iannotta; Man Yang; Christian Celia; Luisa Di Marzio; Joy Wolfram
Journal:  Nano Today       Date:  2021-04-27       Impact factor: 18.962

Review 8.  ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.

Authors:  Arzu Kalayci; C Michael Gibson; Paul M Ridker; Samuel D Wright; Bronwyn A Kingwell; Serge Korjian; Gerald Chi; Jane J Lee; Pierluigi Tricoci; S Hassan Kazmi; Clara Fitzgerald; Alka Shaunik; Gail Berman; Danielle Duffy; Peter Libby
Journal:  Curr Atheroscler Rep       Date:  2022-05-07       Impact factor: 5.967

Review 9.  Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity.

Authors:  Bronwyn A Kingwell; Stephen J Nicholls; Elena Velkoska; Svetlana A Didichenko; Danielle Duffy; Serge Korjian; C Michael Gibson
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

10.  Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein.

Authors:  Andrea J Luthi; Nicholas N Lyssenko; Duyen Quach; Kaylin M McMahon; John S Millar; Kasey C Vickers; Daniel J Rader; Michael C Phillips; Chad A Mirkin; C Shad Thaxton
Journal:  J Lipid Res       Date:  2015-02-04       Impact factor: 5.922
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.